Liver Failure/Cirrhosis/Portal Hypertension

You have full text access to this OnlineOpen article

Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test†

  1. Jasmohan S. Bajaj1,2,‡,*,
  2. Kia Saeian2,
  3. Christine M. Schubert3,
  4. Muhammad Hafeezullah2,
  5. Jose Franco2,
  6. Rajiv R. Varma2,
  7. Douglas P. Gibson4,
  8. Raymond G. Hoffmann5,
  9. R. Todd Stravitz1,
  10. Douglas M. Heuman1,
  11. Richard K. Sterling1,
  12. Mitchell Shiffman1,
  13. Allyne Topaz1,
  14. Sherry Boyett1,
  15. Debulon Bell1,
  16. Arun J. Sanyal1

Article first published online: 15 JUN 2009

DOI: 10.1002/hep.23128

Issue

Hepatology

Hepatology

Volume 50, Issue 4, pages 1175–1183, October 2009

Additional Information

How to Cite

Bajaj, J. S., Saeian, K., Schubert, C. M., Hafeezullah, M., Franco, J., Varma, R. R., Gibson, D. P., Hoffmann, R. G., Stravitz, R. T., Heuman, D. M., Sterling, R. K., Shiffman, M., Topaz, A., Boyett, S., Bell, D. and Sanyal, A. J. (2009), Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test. Hepatology, 50: 1175–1183. doi: 10.1002/hep.23128

Author Information

  1. 1

    Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA

  2. 2

    Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI

  3. 3

    Department of Biostatistics, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA

  4. 4

    Division of Psychology, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA

  5. 5

    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI

  1. ‡

    fax: 804-675-5816.

*Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, 1201 Broad Rock Boulevard, Richmond, VA 23221

  1. †

    Potential conflict of interest: Dr. Bajaj is a consultant for, advises, and received grants from Salix and Ocera. Dr. Heuman received grants from Salix and Ocera. Dr. Sterling is a consultant for, advises, is on the speakers' bureau of, and received grants from Roche. He is also a consultant for and is on the speakers' bureau of Schering-Plough. He advises Vertex and Wako. He received grants from Bristol-Myers Squibb and GlaxoSmithKline. He also advises and received grants from Bayers. Dr. Shiffman advises and is on the speakers' bureau of Salix.

Publication History

  1. Issue published online: 28 SEP 2009
  2. Article first published online: 15 JUN 2009
  3. Accepted manuscript online: 15 JUN 2009 12:00AM EST
  4. Manuscript Accepted: 9 JUN 2009
  5. Manuscript Received: 5 MAY 2009

Funded by

  • American College of Gastroenterology Junior Faculty Development Award
  • Clinical research center. Grant Numbers: MO1-RR00065, MO1-RR00058
  • National Center for Research Resources
  • National Institutes of Health

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (378K)

References

  • 1
    Hartmann IJ, Groeneweg M, Quero JC, Beijeman SJ, de Man RA, Hop WC, et al. The prognostic significance of subclinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 2029–2034.
  • 2
    Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 2718–2723.
  • 3
    Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. HEPATOLOGY 1998; 28: 45–49.
  • 4
    Ortiz M, Jacas C, Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42(Suppl.): S45–S53.
  • 5
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716–721.
  • 6
    Bajaj JS, Hafeezullah M, Franco J, Varma RR, Hoffmann RG, Knox JF, et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology 2008; 135: 1591–1600.
  • 7
    Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 2007; 102: 754–760.
  • 8
    Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A 1999; 96: 8301–8306.
  • 9
    Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. HEPATOLOGY 2008; 47: 596–604.
  • 10
    Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. HEPATOLOGY 2004; 39: 739–745.
  • 11
    Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 2007; 102: 1903–1909.
  • 12
    Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol 2008; 6: 1135–1139; quiz: 1065.
  • 13
    Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol 2008; 103: 1674–1681.
  • 14
    Virginia Department of Motor Vehicles. 2007 Virginia traffic fatalities by jurisdiction. http://www.dmv.state.va.us/webdoc/pdf/vacrashsummary_07.pdf. Accessed June 2009.
  • 15
    Wisconsin Department of Transportation. 2007 Wisconsin traffic crash facts. http://www.dot.wisconsin.gov/safety/motorist/crashfacts/docs/crash-general.pdf. Accessed June 2009.
  • 16
    Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umilta C, et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 2005; 20: 381–392.
  • 17
    Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768–773.
  • 18
    Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Berding G, Ahl B. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 2005; 20: 359–367.
  • 19
    Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 13–19.
  • 20
    Bajaj JS, Hafeezullah M, Zadvornova Y, Martin E, Schubert CM, Gibson DP, et al. The effect of fatigue on driving skills in patients with hepatic encephalopathy. Am J Gastroenterol 2009; 104: 898–905.
  • 21
    Watanabe A, Tuchida T, Yata Y, Kuwabara Y. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10: 239–248.
  • 22
    Wu H, Yan-Go F. Self-reported automobile accidents involving patients with obstructive sleep apnea. Neurology 1996; 46: 1254–1257.
  • 23
    Annas GJ. Doctors, drugs, and driving: tort liability for patient-caused accidents. N Engl J Med 2008; 359: 521–525.
  • 24
    American Medical Association. Chapter 8: State Licensing Requirements and Reporting Laws. http://www.ama-assn.org/ama1/pub/upload/mm/433/chapter8.pdf. Accessed June 2009.
  • 25
    Snyder KM, Ganzini L. Outcomes of Oregon's law mandating physician reporting of impaired drivers. J Geriatr Psychiatry Neurol 2009; doi:10.1177/0891988709332943.
  • 26
    Marshall SC. The role of reduced fitness to drive due to medical impairments in explaining crashes involving older drivers. Traffic Inj Prev 2008; 9: 291–298.
  • 27
    Martin AJ, Marottoli R, O'Neill D. Driving assessment for maintaining mobility and safety in drivers with dementia. Cochrane Database Syst Rev 2009;CD006222.
  • 28
    Reimer B, D'Ambrosio LA, Coughlin JF, Fried R, Biederman J. Task-induced fatigue and collisions in adult drivers with attention deficit hyperactivity disorder. Traffic Inj Prev 2007; 8: 290–299.
  • 29
    Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 2002; 8: 655–672.
  • 30
    Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. HEPATOLOGY 2007; 45: 549–559.
View Full Article (HTML) Get PDF (378K)